Femme et Homme
- | Pays :
- Tunisia
- India
- Finland
- Les 10 autres...
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to compare, after 8 weeks, the efficacy of SR58611A vs. placebo in patients with Major Depressive Disorder who are on concomitant treatment with escitalopram. The secondary objective of this study is to document clinical safety and tolerability of SR58611A in association with escitalopram.
Critère d'inclusion
- Major Depressive Disorder